Africa faces more health challenges than any other part of the world. Weak health systems and limited access to clean water contribute to frequent disease outbreaks. A whopping 80% of medicines used in Africa are imported, making countries vulnerable to price shifts and global supply issues.
The COVID-19 pandemic highlighted these weaknesses. Many African nations struggled to access essential supplies like masks, medical oxygen, and vaccines. This wasn’t just about logistics; it showed a deeper lack of readiness.
To improve this situation, local pharmaceutical production needs to become a priority. Creating medicine locally means countries can stock what they actually need, like vaccines for diseases common in Africa. It also helps them respond quickly to new health threats. Currently, Africa is not prepared to meet the G7’s 100 Days Mission, which aims for diagnostics and vaccines to be available within 100 days of a pandemic threat.
Some steps are being taken. The African Union recently put out a list of 24 critical medical products for regional manufacturing. This follows earlier plans that struggled due to lack of political support and poor financing. History shows that strong execution and regional cooperation are vital for success.
To move forward, African governments must prioritize local production. Investments, tax incentives, and partnerships can help build the necessary infrastructure. The African Medicines Agency can help streamline processes and set quality standards. The African Continental Free Trade Area can promote the use of locally made products.
At its core, this is about resilience. Countries with their own medicine supplies can better handle health crises. As external aid decreases, self-sufficiency becomes important for sustainability.
Africa is in the midst of significant change. Homegrown pharmaceutical industries can drive new jobs and improve health equity. The COVID pandemic underscored the importance of Africa meeting its health needs. While international partnerships are essential, they should support, not replace, local production.
According to Francisca Mutapi, a professor of global health at the University of Edinburgh, building local manufacturing is crucial for Africa’s future health security. By investing in their own pharmaceutical capacities, African nations can ensure they are prepared for both current and future health challenges.
